PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
Shreya Kanodia, Eric Wieder, Sijie Lu et al. · 2010
Read PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal by Shreya Kanodia, Eric Wieder, Sijie Lu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011770.txt.
Description
Shreya Kanodia and co-authors studied lasting remissions in chronic myelogenous leukaemia, in PLOS ONE in 2010. Interferon treatment produces complete cytogenetic remission in a minority of patients, and in a few the remission persists after the drug is stopped. Interferon partly works by raising killer T cells specific for a leukaemia peptide called PR1.
The team related those PR1-specific T cells to remissions maintained without further treatment. Their findings suggest immune guards keep the cancer down after interferon withdrawal. That link supports therapies that strengthen such T cells to hold leukaemia in check.
Catalog record
| CREATOR | Shreya Kanodia, Eric Wieder, Sijie Lu et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011770